SPESOLIMAB

SPESOLIMAB was reported 403 times

These side effects are most commonly reported by patients taking SPESOLIMAB:

# Side effect Count
0 GENERALISED PUSTULAR PSORIASIS 82
1 DRUG INEFFECTIVE 54
2 OFF LABEL USE 26
3 PRURITUS 22
4 RASH 20
5 FATIGUE 19
6 PUSTULAR PSORIASIS 19
7 PSORIASIS 16
8 PUSTULE 15
9 MATERNAL EXPOSURE DURING PREGNANCY 14
10 ASTHENIA 13
11 PYREXIA 13
12 DIARRHOEA 12
13 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12
14 URINARY TRACT INFECTION 12
15 ARTHRALGIA 11
16 HEADACHE 11
17 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11
18 ARTHRITIS 10
19 ERYTHEMA 10
20 NAUSEA 10
21 STRESS 10
22 CONDITION AGGRAVATED 9
23 INJECTION SITE PAIN 9
24 SEPSIS 9
25 WEIGHT INCREASED 9
26 DEATH 8
27 DERMATITIS EXFOLIATIVE GENERALISED 8
28 BREAST SWELLING 7
29 INFLAMMATORY PAIN 7
30 INTENTIONAL PRODUCT USE ISSUE 7
31 LIVER DISORDER 7
32 PSORIASIS AREA SEVERITY INDEX INCREASED 7
33 PSORIATIC ARTHROPATHY 7
34 SACROILIITIS 7
35 SKIN EXFOLIATION 7
36 SKIN STRIAE 7
37 SPONDYLITIS 7
38 ILLNESS 6
39 MALAISE 6
40 PAIN IN EXTREMITY 6
41 PERIPHERAL SWELLING 6
42 PNEUMONIA 6
43 SKIN LESION 6
44 THERAPEUTIC PRODUCT EFFECT DECREASED 6
45 COVID-19 5
46 HEPATIC ENZYME INCREASED 5
47 INCORRECT DOSE ADMINISTERED 5
48 INFECTION 5
49 PAIN 5
50 THERAPEUTIC RESPONSE DECREASED 5
51 URTICARIA 5
52 ANAPHYLACTIC REACTION 4
53 BACK PAIN 4
54 BLISTER 4
55 CARDIAC FAILURE 4
56 DEEP VEIN THROMBOSIS 4
57 DRUG HYPERSENSITIVITY 4
58 DRUG INTOLERANCE 4
59 HOSPITALISATION 4
60 HYPERSENSITIVITY 4
61 HYPOTENSION 4
62 INFLAMMATION 4
63 INFLUENZA 4
64 NASOPHARYNGITIS 4
65 PALMOPLANTAR PUSTULOSIS 4
66 PNEUMOCYSTIS JIROVECII PNEUMONIA 4
67 PRODUCT DOSE OMISSION ISSUE 4
68 PRODUCT USE IN UNAPPROVED INDICATION 4
69 RESPIRATORY FAILURE 4
70 SKIN BURNING SENSATION 4
71 SWELLING 4
72 VOMITING 4
73 WEIGHT DECREASED 4
74 ABDOMINAL DISCOMFORT 3
75 ABDOMINAL PAIN UPPER 3
76 ACUTE KIDNEY INJURY 3
77 ACUTE RESPIRATORY DISTRESS SYNDROME 3
78 ANXIETY 3
79 BRONCHITIS 3
80 CARDIAC ARREST 3
81 CARDIAC PACEMAKER REPLACEMENT 3
82 CELLULITIS 3
83 DECREASED APPETITE 3
84 DERMATITIS 3
85 DEVICE MALFUNCTION 3
86 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
87 ECZEMA 3
88 FLUSHING 3
89 GAIT DISTURBANCE 3
90 HYPERTENSION 3
91 IMPAIRED HEALING 3
92 INFLUENZA LIKE ILLNESS 3
93 LETHARGY 3
94 MEMORY IMPAIRMENT 3
95 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3
96 PAIN OF SKIN 3
97 PARAESTHESIA 3
98 PARATHYROID GLAND OPERATION 3
99 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3
100 PULMONARY EMBOLISM 3
101 RENAL IMPAIRMENT 3
102 RHINORRHOEA 3
103 SKIN DISORDER 3
104 STAPHYLOCOCCAL BACTERAEMIA 3
105 SWELLING FACE 3
106 WHITE BLOOD CELL COUNT INCREASED 3
107 WOUND 3
108 ABDOMINAL PAIN 2
109 ALOPECIA 2
110 BLOOD CREATINE INCREASED 2
111 BLOOD GLUCOSE DECREASED 2
112 BLOOD PRESSURE DECREASED 2
113 CARDIAC FAILURE ACUTE 2
114 CATARACT 2
115 CHEST DISCOMFORT 2
116 CHEST PAIN 2
117 CHILLS 2
118 COUGH 2
119 DEPRESSION 2
120 DISCOMFORT 2
121 DISEASE RECURRENCE 2
122 DIZZINESS 2
123 DRUG TOLERANCE 2
124 DRUG-INDUCED LIVER INJURY 2
125 DRY SKIN 2
126 ENDOCARDITIS 2
127 ERYTHEMA MULTIFORME 2
128 EXCESSIVE CERUMEN PRODUCTION 2
129 EXPOSURE DURING PREGNANCY 2
130 FALL 2
131 FEELING ABNORMAL 2
132 FLANK PAIN 2
133 GAIT INABILITY 2
134 GASTROINTESTINAL DISORDER 2
135 HERPES ZOSTER 2
136 HIDRADENITIS 2
137 HYPERGLYCAEMIA 2
138 HYPOACUSIS 2
139 HYPOKALAEMIA 2
140 IMMUNE SYSTEM DISORDER 2
141 INFUSION SITE EXTRAVASATION 2
142 INJECTION SITE BRUISING 2
143 INJECTION SITE ERYTHEMA 2
144 INSOMNIA 2
145 INTENTIONAL DOSE OMISSION 2
146 JOINT SWELLING 2
147 LOWER RESPIRATORY TRACT INFECTION 2
148 MICTURITION URGENCY 2
149 MUSCLE ABSCESS 2
150 MUSCULAR WEAKNESS 2
151 MYOCARDITIS 2
152 NASAL CONGESTION 2
153 NEUTROPHILIA 2
154 NONINFECTIVE GINGIVITIS 2
155 PNEUMONIA ASPIRATION 2
156 PRODUCT ADMINISTRATION ERROR 2
157 PRODUCT QUALITY ISSUE 2
158 PULMONARY OEDEMA 2
159 RADIAL NERVE PALSY 2
160 RASH ERYTHEMATOUS 2
161 RASH MACULAR 2
162 RENAL FAILURE 2
163 SEPTIC SHOCK 2
164 SKIN ATROPHY 2
165 SKIN FRAGILITY 2
166 SKIN HAEMORRHAGE 2
167 STAPHYLOCOCCAL INFECTION 2
168 THERAPY NON-RESPONDER 2
169 THROAT IRRITATION 2
170 TRANSIENT ISCHAEMIC ATTACK 2
171 TREATMENT FAILURE 2
172 UPPER RESPIRATORY TRACT INFECTION 2
173 URINARY TRACT DISORDER 2
174 UROSEPSIS 2
175 ABDOMINAL WALL ABSCESS 1
176 ABNORMAL DREAMS 1
177 ABORTION INDUCED 1
178 ACCIDENTAL OVERDOSE 1
179 ACIDOSIS 1
180 ADRENAL NEOPLASM 1
181 AFFECTIVE DISORDER 1
182 AMENORRHOEA 1
183 ANAEMIA 1
184 ANAPHYLACTIC SHOCK 1
185 ANAPHYLACTOID REACTION 1
186 ANGINA PECTORIS 1
187 APATHY 1
188 APPENDICITIS PERFORATED 1
189 ARTHRITIS BACTERIAL 1
190 ASPIRATION 1
191 BACTERIAL SEPSIS 1
192 BEHCET^S SYNDROME 1
193 BENIGN FAMILIAL HAEMATURIA 1
194 BLOOD CREATININE INCREASED 1
195 BLOOD CULTURE POSITIVE 1
196 BLOOD GLUCOSE INCREASED 1
197 BLOOD LACTIC ACID INCREASED 1
198 BLOOD POTASSIUM DECREASED 1
199 BLOOD PRESSURE INCREASED 1
200 BODY TEMPERATURE DECREASED 1
201 BOWEL MOVEMENT IRREGULARITY 1
202 BRAIN INJURY 1
203 BREAST CANCER 1
204 BRONCHIOLITIS 1
205 BRONCHOPULMONARY ASPERGILLOSIS 1
206 BRONCHOSPASM 1
207 BURNING SENSATION 1
208 CARDIAC DEATH 1
209 CEREBROVASCULAR ACCIDENT 1
210 CHOLELITHIASIS 1
211 CHRONIC KIDNEY DISEASE 1
212 CLAVICLE FRACTURE 1
213 CLOSTRIDIUM DIFFICILE INFECTION 1
214 COLITIS ULCERATIVE 1
215 CONSTIPATION 1
216 CONTUSION 1
217 CORNEAL DYSTROPHY 1
218 COSTOCHONDRITIS 1
219 CYSTITIS 1
220 DECREASED ACTIVITY 1
221 DELIRIUM 1
222 DEPRESSED MOOD 1
223 DERMATITIS CONTACT 1
224 DERMATOLOGIC EXAMINATION ABNORMAL 1
225 DERMATOSIS 1
226 DEVICE DELIVERY SYSTEM ISSUE 1
227 DEVICE RELATED BACTERAEMIA 1
228 DEVICE RELATED SEPSIS 1
229 DISEASE PROGRESSION 1
230 DISTRIBUTIVE SHOCK 1
231 DISTURBANCE IN ATTENTION 1
232 DRUG ERUPTION 1
233 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
234 DRUG RESISTANCE 1
235 DUODENAL ULCER HAEMORRHAGE 1
236 DYSPEPSIA 1
237 DYSPHAGIA 1
238 DYSPHONIA 1
239 DYSPNOEA 1
240 DYSPNOEA EXERTIONAL 1
241 DYSURIA 1
242 EAR INFECTION 1
243 EAR PAIN 1
244 ELECTROCARDIOGRAM QT PROLONGED 1
245 ELECTROLYTE IMBALANCE 1
246 ENDODONTIC PROCEDURE 1
247 ENERGY INCREASED 1
248 EOSINOPHIL COUNT INCREASED 1
249 EOSINOPHILIA 1
250 EPIDIDYMITIS 1
251 EPILEPSY 1
252 EPISTAXIS 1
253 ESCHERICHIA BACTERAEMIA 1
254 EXTRA DOSE ADMINISTERED 1
255 EYE CONTUSION 1
256 EYE PRURITUS 1
257 EYE SWELLING 1
258 FACIAL PARALYSIS 1
259 FAECAL VOLUME DECREASED 1
260 FAECES DISCOLOURED 1
261 FAECES HARD 1
262 FEAR 1
263 FLATULENCE 1
264 FLUID RETENTION 1
265 FUNGAL INFECTION 1
266 FURUNCLE 1
267 GALLBLADDER OPERATION 1
268 GASTROINTESTINAL MOTILITY DISORDER 1
269 GENERAL PHYSICAL HEALTH DETERIORATION 1
270 GINGIVAL BLEEDING 1
271 GINGIVAL RECESSION 1
272 HAEMORRHAGE 1
273 HAEMORRHAGIC DIATHESIS 1
274 HALLUCINATION 1
275 HEAD INJURY 1
276 HEART RATE DECREASED 1
277 HEPATIC FUNCTION ABNORMAL 1
278 HEPATITIS 1
279 HEPATITIS B 1
280 HEPATOCELLULAR CARCINOMA 1
281 HOSPICE CARE 1
282 HYPERCALCAEMIA 1
283 HYPERPYREXIA 1
284 HYPERTHERMIA 1
285 HYPOAESTHESIA 1
286 HYPOALBUMINAEMIA 1
287 HYPOBARISM 1
288 HYPOCALCAEMIA 1
289 HYPOGLYCAEMIA 1
290 HYPOMAGNESAEMIA 1
291 HYPOPROTEINAEMIA 1
292 HYPOTHERMIA 1
293 HYPOXIA 1
294 HYSTERECTOMY 1
295 ILL-DEFINED DISORDER 1
296 IMMUNE-MEDIATED MYOCARDITIS 1
297 INCORRECT DRUG ADMINISTRATION RATE 1
298 INCORRECT PRODUCT ADMINISTRATION DURATION 1
299 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
300 INFESTATION 1
301 INFLAMMATORY MARKER INCREASED 1
302 INFREQUENT BOWEL MOVEMENTS 1
303 INFUSION SITE ERYTHEMA 1
304 INJECTION SITE CELLULITIS 1
305 INJECTION SITE PRURITUS 1
306 INJECTION SITE SCAB 1
307 INJECTION SITE SWELLING 1
308 INJECTION SITE URTICARIA 1
309 INJURY 1
310 INTERNAL HAEMORRHAGE 1
311 INTESTINAL PERFORATION 1
312 INVASIVE DUCTAL BREAST CARCINOMA 1
313 IRRITABILITY 1
314 KERION 1
315 KLEBSIELLA BACTERAEMIA 1
316 LEIOMYOSARCOMA METASTATIC 1
317 LEUKAEMOID REACTION 1
318 LIMB DISCOMFORT 1
319 LIP DISORDER 1
320 LIP SWELLING 1
321 LIVER INJURY 1
322 LYMPHADENECTOMY 1
323 LYMPHADENITIS 1
324 LYMPHADENOPATHY 1
325 LYMPHOMATOID PAPULOSIS 1
326 MAST CELL ACTIVATION SYNDROME 1
327 MATERNAL EXPOSURE DURING BREAST FEEDING 1
328 MEDICAL DEVICE SITE ABSCESS 1
329 MENINGITIS 1
330 METASTASES TO BONE 1
331 METASTASES TO LIVER 1
332 METASTASES TO LUNG 1
333 MIGRAINE 1
334 MUSCLE SPASMS 1
335 MUSCLE TWITCHING 1
336 MYALGIA 1
337 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1
338 MYOCARDIAL INFARCTION 1
339 MYRINGITIS 1
340 NECK PAIN 1
341 NEPHROPATHY 1
342 NERVOUSNESS 1
343 NEURALGIA 1
344 NONSPECIFIC REACTION 1
345 OCCIPITAL NEURALGIA 1
346 OEDEMA 1
347 OEDEMA PERIPHERAL 1
348 OPPORTUNISTIC INFECTION 1
349 ORAL DISCOMFORT 1
350 ORAL MUCOSAL BLISTERING 1
351 OSTEOMYELITIS 1
352 OSTEOPOROSIS 1
353 PANCREATITIS 1
354 PANCREATITIS ACUTE 1
355 PAPULE 1
356 PARANEOPLASTIC DERMATOSIS 1
357 PARASPINAL ABSCESS 1
358 PARKINSON^S DISEASE 1
359 PERIORBITAL OEDEMA 1
360 PLATELET COUNT DECREASED 1
361 PLEURAL EFFUSION 1
362 PNEUMONITIS 1
363 POLLAKIURIA 1
364 POST-ACUTE COVID-19 SYNDROME 1
365 PROCEDURAL COMPLICATION 1
366 PROCEDURAL HEADACHE 1
367 PRODUCT USE ISSUE 1
368 PRODUCTIVE COUGH 1
369 PROSTATE CANCER 1
370 PULMONARY SEPSIS 1
371 PULSELESS ELECTRICAL ACTIVITY 1
372 PYODERMA GANGRENOSUM 1
373 RASH PRURITIC 1
374 RASH PUSTULAR 1
375 REBOUND EFFECT 1
376 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
377 RESPIRATORY ARREST 1
378 RESPIRATORY DISTRESS 1
379 RESPIRATORY TRACT INFECTION 1
380 ROAD TRAFFIC ACCIDENT 1
381 ROSACEA 1
382 SINUSITIS 1
383 SKIN DISCOLOURATION 1
384 SKIN FISSURES 1
385 SKIN INFECTION 1
386 SKIN ULCER 1
387 SKIN WEEPING 1
388 SKIN WRINKLING 1
389 SLEEP DEFICIT 1
390 SOLAR LENTIGO 1
391 SOMNOLENCE 1
392 SPEECH DISORDER 1
393 SPINAL OPERATION 1
394 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1
395 STAPHYLOCOCCAL SEPSIS 1
396 SUICIDAL IDEATION 1
397 SUPRAVENTRICULAR TACHYCARDIA 1
398 SUSPECTED OFF LABEL USE 1
399 SWELLING OF EYELID 1
400 TACHYPNOEA 1
401 THERAPEUTIC RESPONSE SHORTENED 1
402 THROMBOCYTOPENIA 1
403 THROMBOPHLEBITIS 1
404 THYROID MASS 1
405 TROPONIN INCREASED 1
406 TUBULOINTERSTITIAL NEPHRITIS 1
407 UNDERDOSE 1
408 UNRESPONSIVE TO STIMULI 1
409 URINARY INCONTINENCE 1
410 VEIN DISORDER 1
411 VEXAS SYNDROME 1
412 VIRAL UPPER RESPIRATORY TRACT INFECTION 1
413 VISUAL IMPAIRMENT 1
414 WHEEZING 1
415 WOUND INFECTION PSEUDOMONAS 1
416 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1